Section Arrow
ASND.NASDAQ
- Ascendis Pharma A/S
Quotes are at least 15-min delayed:2026/01/01 15:36 EST
Regular Hours
Last
 213.24
+3.9 (+1.86%)
Day High 
215.43 
Prev. Close
209.34 
1-M High
229.94 
Volume 
460.35K 
Bid
196.05
Ask
222
Day Low
207.28 
Open
209.24 
1-M Low
192.28 
Market Cap 
12.79B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 207.55 
20-SMA 207.05 
50-SMA 205.97 
52-W High 229.94 
52-W Low 118.03 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.82/4.20
Enterprise Value
13.16B
Balance Sheet
Book Value Per Share
-3.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
363.64M
Operating Revenue Per Share
2.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4167+0.0462+12.47%-- 
OTLKOutlook Therapeutics1.58-0.285-15.28%0.58PE
VNDAVanda Pharmaceuticals8.82+1.79+25.46%126.25PE
SLSSELLAS Life Sciences Group3.77+0.46+13.90%-- 
FBLGFibroBiologics0.2249-0.017-7.03%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.